Chatham Capital Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-5,080
| Closed | -$268K | – | 152 |
|
|
2017
Q1 | $268K | Buy |
5,080
+640
| +14% | +$33.8K | 0.07% | 134 |
|
|
2016
Q4 | $214K | Sell |
4,440
-302
| -6% | -$14.6K | 0.06% | 136 |
|
|
2016
Q3 | $256K | Sell |
4,742
-298
| -6% | -$16.1K | 0.08% | 127 |
|
|
2016
Q2 | $273K | Sell |
5,040
-280
| -5% | -$15.2K | 0.08% | 125 |
|
|
2016
Q1 | $270K | Sell |
5,320
-1,000
| -16% | -$50.8K | 0.09% | 121 |
|
|
2015
Q4 | $319K | Sell |
6,320
-8,760
| -58% | -$442K | 0.1% | 114 |
|
|
2015
Q3 | $725K | Sell |
15,080
-3,360
| -18% | -$162K | 0.24% | 75 |
|
|
2015
Q2 | $960K | Sell |
18,440
-920
| -5% | -$47.9K | 0.27% | 77 |
|
|
2015
Q1 | $1.12M | Buy |
19,360
+320
| +2% | +$18.5K | 0.33% | 64 |
|
|
2014
Q4 | $1.02M | Buy |
+19,040
| New | +$1.02M | 0.3% | 66 |
|